Terminated PHASE3 INTERVENTIONAL 3-arm NCT02315417

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Sponsor: XOMA (US) LLC

Conditions Pyoderma Gangrenosum

Interventions Placebo gevokizumab gevokizumab open-label

Updated 7 times since 2017 Last updated: Apr 25, 2016 Started: Nov 30, 2014 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from XOMA (US) LLC

More terminations from XOMA (US) LLC

Other Pyoderma Gangrenosum trials with similar outcome

Browse all Pyoderma Gangrenosum trials

Listed as NCT02315417, this PHASE3 trial focuses on Pyoderma Gangrenosum and remains terminated or withdrawn. Sponsored by XOMA (US) LLC, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

XOMA (US) LLC

Data source: XOMA (US) LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Columbus, United States , Coral Gables, United States , Houston, United States , Lebanon, United States , Lubbock, United States , New York, United States , North Miami Beach, United States , Philadelphia, United States , Portland, United States and 2 more locations